Keros Therapeutics Stock In The News
| KROS Stock | USD 11.58 0.11 0.96% |
Our overall analysis of Keros Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Keros Therapeutics. The specific impact of Keros Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Keros Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Keros Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Keros Therapeutics Backtesting and Keros Therapeutics Hype Analysis. For more information on how to buy Keros Stock please use our How to Invest in Keros Therapeutics guide.
Keros |
Keros Therapeutics Today Top News and Investor Outlook
Keros Therapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Keros and other traded companies coverage with news coverage. We help investors stay connected with Keros headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Keros Stock performance. Please note that trading solely based on the Keros Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Keros Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Keros earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Keros Therapeutics that are available to investors today. That information is available publicly through Keros media outlets and privately through word of mouth or via Keros internal channels. However, regardless of the origin, that massive amount of Keros data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Keros Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Keros Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Keros Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Keros Therapeutics alpha.
Keros Largest EPS Surprises
Earnings surprises can significantly impact Keros Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-03-25 | 2020-12-31 | -0.57 | -0.49 | 0.08 | 14 | ||
2021-05-06 | 2021-03-31 | -0.58 | -0.68 | -0.1 | 17 | ||
2024-11-04 | 2024-09-30 | -1.28 | -1.41 | -0.13 | 10 | ||
2024-05-08 | 2024-03-31 | -1.35 | -1.21 | 0.14 | 10 | ||
2023-05-04 | 2023-03-31 | -1.12 | -1.26 | -0.14 | 12 | ||
2022-05-05 | 2022-03-31 | -0.86 | -1.01 | -0.15 | 17 |
Keros Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Keros Therapeutics Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
3rd of March 2025
Keros Therapeutics, Inc. Receives Consensus Rating of Moderate Buy from Analysts - MarketB... at news.google.com
27th of February 2025
Keros Therapeutics stock target cut to 40 at H.C. Wainwright - Investing.com at news.google.com
26th of February 2025
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 202... at globenewswire.com
18th of February 2025
Acquisition by Rovaldi Christopher of 60000 shares of Keros Therapeutics subject to Rule 1... at MacroaxisInsider
6th of February 2025
Kairos Pharma Oral Presentation on Its Investigational Compound KROS 101 at the 13th AACR-... at finance.yahoo.com
28th of January 2025
Kairos Pharma to Present Short Talk on Its Investigational Compound KROS 101 at the 13th A... at businesswire.com
24th of January 2025
KEROS ALERT Bragar Eagel Squire, P.C. is Investigating - GlobeNewswire at news.google.com
16th of January 2025
Heres Why Keros Therapeutics is Poised for a Turnaround After Losing -39.17 percent in 4 W... at finance.yahoo.com
Keros Therapeutics Investors Sentiment
The influence of Keros Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Keros. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Keros Therapeutics' public news can be used to forecast risks associated with an investment in Keros. The trend in average sentiment can be used to explain how an investor holding Keros can time the market purely based on public headlines and social activities around Keros Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Keros Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Keros Therapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Keros Therapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Keros Therapeutics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Keros Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Keros Therapeutics' short interest history, or implied volatility extrapolated from Keros Therapeutics options trading.
Additional Tools for Keros Stock Analysis
When running Keros Therapeutics' price analysis, check to measure Keros Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Keros Therapeutics is operating at the current time. Most of Keros Therapeutics' value examination focuses on studying past and present price action to predict the probability of Keros Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Keros Therapeutics' price. Additionally, you may evaluate how the addition of Keros Therapeutics to your portfolios can decrease your overall portfolio volatility.